XJPX9158
Market cap293mUSD
Jan 14, Last price
1,581.00JPY
1D
-1.06%
1Q
-0.63%
IPO
-59.46%
Name
CUC Inc
Chart & Performance
P/E
17.86
P/S
1.40
EPS
88.52
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
33.03b
-6.21%
Net income
2.60b
+7.10%
CFO
4.16b
+76.33%
Profile
CUC Inc. offers healthcare services in Japan, Asia and internationally. It provides hospital care, dialysis care, visiting nurses, and home hospices services, as well as management support services for healthcare institutions; and healthcare consulting services. The company was founded in 2014 and is based in Minato-Ku, Japan. CUC Inc. operates as a subsidiary of M3 Inc.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | |
| Income | ||||
Revenues | 33,025,000 -6.21% | 35,210,000 -0.29% | 35,314,000 112.66% | |
Cost of revenue | 29,308,000 | 31,449,000 | 29,856,000 | |
Unusual Expense (Income) | ||||
NOPBT | 3,717,000 | 3,761,000 | 5,458,000 | |
NOPBT Margin | 11.26% | 10.68% | 15.46% | |
Operating Taxes | 1,531,000 | 1,230,000 | 1,402,000 | |
Tax Rate | 41.19% | 32.70% | 25.69% | |
NOPAT | 2,186,000 | 2,531,000 | 4,056,000 | |
Net income | 2,595,000 7.10% | 2,423,000 -10.49% | 2,707,000 146.09% | |
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | 13,113,000 | 24,000 | ||
BB yield | -17.53% | |||
| Debt | ||||
Debt current | 3,159,000 | 16,929,000 | 11,374,000 | |
Long-term debt | 31,845,000 | 9,935,000 | 7,744,000 | |
Deferred revenue | 266,000 | 228,000 | ||
Other long-term liabilities | 1,427,000 | 355,000 | 222,000 | |
Net debt | 22,392,000 | 19,906,000 | 11,420,000 | |
| Cash flow | ||||
Cash from operating activities | 4,156,000 | 2,357,000 | 6,616,000 | |
CAPEX | (4,859,000) | (5,583,000) | (848,000) | |
Cash from investing activities | (14,746,000) | (6,682,000) | (1,468,000) | |
Cash from financing activities | 14,373,000 | 3,972,000 | (4,433,000) | |
FCF | (6,398,000) | (4,212,000) | 5,522,000 | |
| Balance | ||||
Cash | 8,256,000 | 4,197,000 | 4,377,000 | |
Long term investments | 4,356,000 | 2,761,000 | 3,321,000 | |
Excess cash | 10,960,750 | 5,197,500 | 5,932,300 | |
Stockholders' equity | 20,243,000 | 10,662,000 | 8,654,000 | |
Invested Capital | 45,190,250 | 28,406,500 | 17,416,700 | |
ROIC | 5.94% | 11.05% | 21.28% | |
ROCE | 6.45% | 10.75% | 21.94% | |
| EV | ||||
Common stock shares outstanding | 27,613 | 21,272 | 20,870 | |
Price | 2,709.00 | |||
Market cap | 74,803,815 | |||
EV | 97,884,815 | |||
EBITDA | 5,523,000 | 4,982,000 | 6,526,000 | |
EV/EBITDA | 17.72 | |||
Interest | 285,000 | 99,000 | 100,000 | |
Interest/NOPBT | 7.67% | 2.63% | 1.83% | |